CO66 Reduction in Migraine-Associated Burden over 24 Weeks of Treatment with Eptinezumab in Patients with Chronic Migraine

Abstract

Authors

P McAllister D Kudrow R Cady J Hirman A Ettrup

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×